Compound 2378
Identifiers
- Canonical SMILES:
Cc1nnc2COCc3ccccc3-n12
- IUPAC name:
3-methyl-8-oxa-2,4,5-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene - InChi:
InChI=1S/C11H11N3O/c1-8-12-13-11-7-15-6-9-4-2-3-5-10(9)14(8)11/h2-5H,6-7H2,1H3
- InChiKey:
HEEIZXCFEVISIX-UHFFFAOYSA-N
External links
![]() 58923143 |
![]() CHEMBL4587486 |
CGJ |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 0 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 201.09 g/mol | |||
| HBA | 4 | |||
| HBD | 0 | |||
| HBA + HBD | 4 | |||
| AlogP | 0.60 | |||
| TPSA | 39.94 | |||
| RB | 0 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4250 | Alprazolam | DB00404 | |
| 0.4245 | 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID | DB07852 | |
| 0.4204 | Estazolam | DB01215 | |
| 0.4156 | AMG-208 | DB08079 | |
| 0.4059 | Adinazolam | DB00546 | |
| 0.4048 | Triazolam | DB00897 | |
| 0.3817 | CRA_1801 | DB03016 | |
| 0.3750 | Pyrazolam | DB14718 | |
| 0.3736 | Nitrazolam | DB14717 | |
| 0.3730 | CRA_1144 | DB03643 | |
| 0.3730 | 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine | DB02287 | |
| 0.3717 | Meradimate | DB11096 | |
| 0.3701 | Deferasirox | DB01609 | |
| 0.3676 | 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine | DB01905 | |
| 0.3672 | Doxylamine | DB00366 |




